Beatriz Sanchez Alamo

Medicine and Dentistry

1. Vasculitis 100%
2. Prognostic Factor 57%
3. Development 50%
4. Patient 50%
5. ANCA Associated Vasculitis 50%
6. Kidney Function 50%
7. Cancer 29%
8. Therapeutic Procedure 27%
9. Survival Rate 23%
10. Therapeutics 22%
11. End Stage Renal Disease 21%
12. Recurrence Risk 16%
13. Clinical Trial 16%
14. Comorbidity 16%
15. Biological Marker 16%
16. Immunoassay 16%
17. Glomerulonephritis 16%
18. Disease Assessment 16%
19. Randomized Controlled Trial 14%
20. Renal Replacement Therapy 14%
21. Scoring System 14%
22. Cardiovascular Disease 12%
23. Age Groups 11%
24. Follow up 11%
25. Early Diagnosis 7%
26. Cumulative Incidence 7%
27. Hazard Ratio 7%
28. Kidney Injury 7%
29. Renal Biopsy 7%
30. Patient Population 7%
31. Kidney Transplantation 7%
32. Chronic Kidney Disease 7%
33. Kidney Graft 7%
34. Infection 7%
35. Glomerulus 7%
36. Observation 5%
37. Proportional Hazards Model 5%
38. Cohort Analysis 5%
39. Male 5%
40. Survival Estimate 5%
41. Low Platelet Count 5%
42. Glomerular Filtration Rate 5%
43. Laboratory 5%
44. Relative Survival 5%